Dominik Schumacher, Tubulis CEO
March 14, 2024 06:00 AM EDT
Financing
Startups

Ger­man ADC biotech Tubu­lis rais­es $138M to en­ter the clin­ic and ex­pand in US

Kyle LaHucik

Senior Reporter

Mu­nich-based Tubu­lis has brought in promi­nent Eu­ro­pean and US in­vestors to back its work in an­ti­body-drug con­ju­gates, which have tak­en on­col­o­gy R&D by

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times